Reliva

Aurora Cannabis Analysts On Pros, Cons Of Entry Into US CBD Market

Aurora Cannabis Inc (NYSE: ACB) shares are on a roll yet again, this time in reaction to its announcement that it is entering the U.S.

Aurora Cannabis Buys Reliva, Enters US CBD Market

Aurora Cannabis (NYSE: ACB) announced Wednesday afternoon it will acquire CBD platform Reliva for $40 million in Aurora common shares. What To Know About The Deal Aurora Cannabis is a Canadian licensed cannabis producer, headquartered in Edmonton.